GlaxoSmithKline NZ Limited
GlaxoSmithKline NZ Limited, commonly referred to as GSK, is a prominent player in the pharmaceutical and healthcare industry, headquartered in New Zealand. Established in 2000, GSK has made significant strides in developing innovative medicines, vaccines, and consumer healthcare products, focusing on areas such as respiratory, HIV, and immunology. With a strong operational presence across the Asia-Pacific region, GSK is recognised for its commitment to research and development, leading to groundbreaking therapies that address unmet medical needs. The company’s core offerings, including its renowned vaccines and prescription medications, are distinguished by their efficacy and safety profiles. GSK's dedication to sustainability and public health has solidified its market position, making it a trusted name in healthcare. Notable achievements include advancements in vaccine technology and a robust pipeline of new treatments, underscoring GSK's role as a leader in the global healthcare landscape.
DitchCarbon Score
How does GlaxoSmithKline NZ Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
GlaxoSmithKline NZ Limited's score of 62 is higher than 97% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
GlaxoSmithKline NZ Limited's reported carbon emissions
GlaxoSmithKline NZ Limited currently does not have available carbon emissions data, as no specific figures have been provided. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that the company may still be in the early stages of formalising its climate commitments or reporting on its emissions. In the pharmaceutical industry, companies are increasingly focusing on sustainability and reducing their carbon footprints, often setting ambitious targets aligned with global climate goals. It is essential for GlaxoSmithKline NZ Limited to establish clear emissions reduction strategies to contribute effectively to climate action and enhance its environmental responsibility.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GlaxoSmithKline NZ Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
